VanEck Pharmaceutical ETF Rating $88.06 -0.33 (-0.37%) Closing price 07/3/2025 03:46 PM EasternExtended Trading$88.13 +0.07 (+0.09%) As of 07/3/2025 04:07 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Ratings Stock AnalysisChartDividendHeadlinesHoldingsOptions ChainOwnershipRatingsShort InterestTrendsBuy This Stock VanEck Pharmaceutical ETF Aggregate Rating and Price Target (2025)How MarketBeat Aggregates ETF Rating and Price TargetMarketBeat calculates the aggregate rating and price target for an ETF by considering the weight of each stock in its portfolio. These ratings and price targets are based on the most recent ratings given by Wall Street analysts over the past year. The aggregate rating reviews the ETF's overall performance and is categorized as strong sell, sell, reduce, hold, moderate buy, buy, or strong buy. The aggegreate price target represents the average potential upside for the consensus price target of individual holdings in the ETF.PPH Aggregate RatingModerate Buy 2.66Holdings in PPH have an aggregate rating of Moderate Buy based on 276 analyst ratings issued in the past year covering 22 companies (92.1% of the portfolio).PPH Aggregate Price Target$88.06High Prediction$88.06Average Prediction$88.06Low Prediction$88.06Holdings in PPH have an aggregate price target of $88.06 and a range of $88.06 to $88.06 covering 22 companies (92.1% of the portfolio).PPH Consensus Ratings of HoldingsStrong Buy0 Strong Buy rating(s)Buy5 Buy rating(s)Moderate Buy10 Moderate Buy rating(s)Hold6 Hold rating(s)Reduce1 Reduce rating(s)Sell0 Sell rating(s)Strong Sell0 Strong Sell rating(s) Ratings for Stocks Held by VanEck Pharmaceutical ETF Strong Sell Sell Reduce Hold Moderate Buy Buy Strong Buy Ratings for the Top 22 PPH Holdings Export to ExcelWeight In ETFCompanyShare PriceMarketRank™Consensus Rating ScoreConsensus Price TargetPossible UpsideNumber of RatingsIndicator(s)ViewRatings18.99%LLYEli Lilly and Company$779.60+0.0%4.9863 of 5 stars2.75$1,011.61 29.8%20Trending News10.00%JNJJohnson & Johnson$155.90+0.2%4.8501 of 5 stars2.55$170.88 9.6%20Positive News7.43%NVONovo Nordisk A/S$69.05-1.1%4.7602 of 5 stars2.27$112.00 62.2%11Positive News5.84%MRKMerck & Co., Inc.$80.97-1.7%4.9962 of 5 stars2.43$109.19 34.8%21Positive News4.67%MCKMcKesson$719.30+2.0%4.3453 of 5 stars2.86$696.42 -3.2%14Trending NewsAnalyst UpgradeAnalyst Revision4.60%PFEPfizer$25.45+0.5%4.9764 of 5 stars2.45$28.55 12.2%22Trending News4.53%ABBVAbbVie$189.50-0.7%4.9079 of 5 stars2.81$211.29 11.5%27Trending NewsAnalyst Revision4.52%SNYSanofi$48.89-0.9%4.1749 of 5 stars3.11$61.50 25.8%9Analyst Forecast4.41%AZNAstraZeneca$69.60-2.2%2.3398 of 5 stars2.83$85.00 22.1%6Positive News4.35%ZTSZoetis$159.19+0.1%4.8379 of 5 stars3.00$212.13 33.3%10News CoveragePositive News4.32%BMYBristol Myers Squibb$47.02-1.3%4.9292 of 5 stars2.32$58.00 23.4%22Positive News4.30%GSKGSK$38.26-0.6%2.3623 of 5 stars2.10$37.38 -2.3%10Options Volume3.85%CORCencora$296.23+1.7%4.6773 of 5 stars2.82$306.33 3.4%11News CoveragePositive NewsAnalyst Revision3.69%HLNHaleon$10.36+0.9%2.61 of 5 stars2.73$12.33 19.0%11News Coverage2.91%TAKTakeda Pharmaceutical$15.55+0.8%1.2677 of 5 stars3.0011.58%TEVATeva Pharmaceutical Industries$17.054.1422 of 5 stars3.22$24.13 41.5%90.67%VTRSViatris$9.25-1.0%3.2993 of 5 stars1.80$10.40 12.4%50.47%JAZZJazz Pharmaceuticals$109.45-0.4%4.9072 of 5 stars2.92$184.00 68.1%13Insider Trade0.34%ELANElanco Animal Health$14.64-0.5%2.2359 of 5 stars2.50$15.33 4.7%8News CoverageAnalyst Forecast0.28%AXSMAxsome Therapeutics$105.36+1.4%4.7487 of 5 stars3.06$172.33 63.6%16Trending NewsAnalyst ForecastAnalyst Revision0.21%PRGOPerrigo$27.20-0.2%4.8447 of 5 stars2.25$33.00 21.3%4Analyst Upgrade0.18%OGNOrganon & Co.$10.08-0.7%4.895 of 5 stars2.50$18.00 78.7%6Trending News This page (NASDAQ:PPH) was last updated on 7/5/2025 by MarketBeat.com Staff From Our PartnersA new rule goes live in July — and the banks are quietly cashing inA little-known regulation quietly goes into effect this July. And it's already being exploited by Wall Stre...American Alternative | SponsoredPresidential Bombshell: $150T Resource to Be Released as soon as this Summer?Something extraordinary is happening in Washington. For the first time in over a century, a sitting Preside...Paradigm Press | SponsoredTrump’s New Order Could Boost Social Security Benefits by 400%If you collect—or plan to collect—Social Security, you need to see this. A new initiative tied to President...InvestorPlace | SponsoredPost-Halving = Profit Season (Here’s How to Win It)It happens like clockwork. Every four years, the crypto market enters a new phase — and for those who know how...Crypto Swap Profits | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredThe End of Elon Musk…?The End of Elon Musk? Don't make him laugh. Jeff Brown has been hearing this same tired story for years, an...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding VanEck Pharmaceutical ETF Please log in to your account or sign up in order to add this asset to your watchlist. Share VanEck Pharmaceutical ETF With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
